Associated Symptoms

In secondary syphilis, kissing lesions are rarely isolated. They are usually accompanied by a constellation of systemic signs that reflect the bacterium’s spread throughout the body.

• Generalized maculopapular rash – often on the trunk, palms, and soles.
• Fever, malaise, and night sweats – constitutional symptoms that can mimic viral illness.
• Lymphadenopathy – non‑tender, rubbery lymph nodes in the groin, epitrochlear, or cervical regions.
• Condylomata lata – broad, moist, wart‑like plaques in the perineal or perianal area.
• Patchy hair loss (alopecia) – “moth‑eaten” pattern on the scalp.
• Neurological symptoms – headache, meningismus, or cranial nerve deficits if early neurosyphilis develops.
• Ocular involvement – uveitis or conjunctivitis in ocular syphilis.
• Joint pain or arthralgia – often migratory and non‑erosive.

When to See a Doctor

Prompt medical evaluation is essential because secondary syphilis is highly contagious and can lead to serious complications if untreated. Seek care if you notice any of the following:

• New or unexplained genital, anal, or oral ulcers—especially if they appear in pairs.
• Accompanying rash on palms, soles, or torso.
• Persistent fever, night sweats, or unexplained weight loss.
• Swollen, non‑tender lymph nodes lasting more than a week.
• Neurological signs such as severe headache, visual changes, or hearing loss.
• Pregnancy or planning to become pregnant – syphilis can cause miscarriage, stillbirth, or congenital infection.

Diagnosis

Diagnosing kissing lesions caused by syphilis involves a combination of clinical assessment, laboratory testing, and sometimes imaging.

Clinical Evaluation

• History – sexual exposure, prior STIs, travel, and symptom timeline.
• Physical examination – careful inspection of all mucocutaneous sites, lymph node assessment, and neurological exam.

Laboratory Tests

1. Serologic screening – non‑treponemal tests (RPR, VDRL) to detect antibodies; quantitative titers help monitor treatment response.
2. Confirmatory treponemal tests – FTA‑ABS, TP‑PA, or enzyme immunoassays (EIA) to verify infection.
3. Dark‑field microscopy – direct visualization of spirochetes from a lesion swab; most useful early in infection.
4. PCR testing – increasingly available for detecting T. pallidum DNA from ulcer exudate.

Additional Work‑up (if indicated)

• CSF analysis – lumbar puncture for VDRL and cell count when neurosyphilis is suspected.
• Pregnancy test – for women of child‑bearing age.
• HIV screening – co‑infection rates are high; recommended for all patients with syphilis.

Treatment Options

The cornerstone of therapy for secondary syphilis, including kissing lesions, is parenteral penicillin. Alternative regimens are reserved for penicillin allergy or specific clinical scenarios.

First‑Line Therapy

• Benzathine penicillin G 2.4 million units IM in a single dose (or divided into two 1.2 million‑unit injections) – the standard regimen for uncomplicated secondary syphilis.

Alternative Regimens (for penicillin‑allergic patients)

• Doxycycline 100 mg orally twice daily for 14 days.
• Ceftriaxone 1 g IM or IV daily for 10‑14 days (use with caution in severe allergy).
• Desensitization to penicillin is recommended for pregnant women or patients with neurosyphilis.

Supportive / Home Care

• Keep lesions clean with gentle soap and water; avoid irritants.
• Use a barrier cream (e.g., petroleum jelly) to reduce friction.
• Abstain from sexual activity until treatment is completed and serologic titers have declined (usually 1‑2 weeks after therapy).
• Notify all recent sexual partners so they can be tested and treated.

Follow‑Up

- Re‑check non‑treponemal titers at 3, 6, and 12 months. A four‑fold decline (e.g., RPR 1:32 to ≤1:8) indicates adequate response.
- If titers do not fall appropriately, retreatment and evaluation for neurosyphilis are warranted.

Prevention Tips

• Consistent condom use – reduces transmission of syphilis and other STIs.
• Limit number of sexual partners and engage in open communication about STI testing.
• Regular screening – at least annually for sexually active adults; more frequently for high‑risk groups (men who have sex with men, sex workers, individuals with HIV).
• Prompt treatment of partners – “treat‑and‑trace” approach lowers community prevalence.
• Pregnancy testing and early prenatal care – syphilis serology is part of routine prenatal labs.
• Vaccination – while no vaccine exists for syphilis, immunizations against hepatitis B and HPV reduce overall STI burden.

Emergency Warning Signs

If any of the following occur, seek emergency medical care immediately:

• Severe headache, confusion, or seizures – possible meningitis or neurosyphilis.
• Sudden loss of vision or eye pain – ocular syphilis.
• Chest pain, shortness of breath, or palpitations – could indicate cardiovascular involvement (aortitis).
• High fever (>38.5 °C) with rapid deterioration.
• Rapidly spreading ulceration, necrosis, or foul‑smelling discharge.

Early recognition and treatment of kissing lesions secondary to syphilis not only resolves the lesions themselves but also prevents the serious long‑term complications of untreated infection.

References: 1. Centers for Disease Control and Prevention. Syphilis – CDC Fact Sheet, 2024. 2. Mayo Clinic. Syphilis: Symptoms and causes, 2023. 3. World Health Organization. Sexually transmitted infections (STIs) fact sheet, 2023. 4. Cleveland Clinic. Secondary syphilis: What to know, 2022.